Tools of Trade: Impact of HD Technology on Patient Outcomes

Tools of Trade: Impact of HD Technology on Patient Outcomes

2:00-4:00

2:00     Monitoring Lung Congestion: What Can We Learn from the CHF Model? – Sandip Mitra MD, FRCP 

2:40     Clinical Significance of Achievable Reductions in B2 M levels – Are We Making a Difference? – Bernard Canaud, MD, PhD

3:20     Expanded Hemodialysis and Clinical Outcomes – Sandip Mitra MD, FRCP 

3:50     Discussion

4:00     Adjourn

Value-Based Care in Nephrology Part 1

Value-Based Care in Nephrology Part 1 

2:00-4:00

Moderator: Andrew Howard, MD

2:00     What Is Value-based Care? – Terry Ketchersid, MD, MBA

2:30     CMS Voluntary Payment Models: KCF, CKCC – Andrew Howard, MD, FACP

3:00     CMS Mandatory Payment Model: ESRD Treatment Choices – Michael Kraus, MD, FACP

3:30     Panel Discussion – Terry Ketchersid, MD, MBA; Michael Kraus, MD, FACP, Kevin Erickson, MD

4:00     Adjourn

PD Fundamentals – PD access

PD Fundamentals – PD access

2:00-4:00

Moderator: Osama El Shamy, MD

2:00      Traditional vs Embedded PD Catheter Insertion: What Are the Outcomes?  John Crabtree, MD

2:30     Surgical Laparoscopic vs Percutaneous PD Catheter Placement – Rajeev Narayan, MD

3:00      Surgical Management of Common Mechanical and Infectious Complications – John Crabtree, MD

3:30      Practical Approach to Create and Maintain a Successful PD Catheter – Shweta Bansal, MD, FASN

3:55       Discussion

4:00     Adjourn

Workshop: PD Prescription Workshop

Workshop: PD Prescription Workshop

2:00-4:00

Moderator: Jeffrey Perl, MD, FRCP

Speakers: Anjay Rastogi, MD, PhD and Jeffrey Perl, MD, FRCP

Peritoneal dialysis prescription involves more than just adjusting prescription to meet target KT/V urea or creatinine clearances.  Areas that not emphasized enough include BP control, and fluid and electrolytes balances and fluid management. This workshop will help you recognize important factors to consider when prescribing PD.  Additionally, we will point out the 10 common mistakes made when prescribing PD.

Implementing Evidence-based Clinical Practice

Implementing Evidence-based Clinical Practice

2:00-4:00

Presented in Cooperation with Kidney Disease: Improving Global Outcomes (KDIGO)

Moderator: Ramesh Khanna, MD

2:00     Symptom Assessment in Dialysis Patients – Jenny Flythe, MD

2:30     Q and A

2:40     Reducing the Burden of Symptoms – Rajnish Mehrotra, MD

3:10     Q and A

3:20     Systems-Level Opportunities Symptom Management – Mark Unruh, MD

3:50     Q and A

4:00     Adjourn

Nuts and Bolts of Urgent Start PD

Nuts and Bolts of Urgent Start PD  

10:30-12:00

Moderator: Nupur Gupta, MD

10:30    Coordination of Care Among Providers: Managing Acute Care Patients – Mihran Naljayan, MD, FASN, FNKF and Michelle Cassin, RN, CPDN

10:10    Catheter Placement – Rajeev Narayan, MD

11:30    Procedures and Protocols – Andrew Wasson, BSN, RN

11:50    Discussion

12:00    Break

Innovations in PD

Innovations in PD

10:30-12:00

Moderator: Preethi Yerram, MD, FASN

10:30    Precision Medicine in PD: Bio-PD – Rajnish Mehrotra, MD, FASN

11:00     Remote Monitoring in PD – Vikram Aggarwal, MD

11:30    Early Detection of PD Peritonitis – TBD

12:00    Break

PD Fundamentals

PD Fundamentals

10:30-12:00

Moderator: Graham Abra, MD

10:30   Is PET Still Relevant in Current Clinical Practice? Peter Blake, MD, FRCPC, FRCPI

11:00   Pathophysiology of PD Membrane Fibrosis and Best Practices for Membrane Preservation – Simon Davies, MBBS, MD, FRCP

11:30   PD Adequacy and Beyond: What Should We Measure? – Jeffrey Perl, MD, FRCP

12:00   Break

RD Breakout II

RD Breakout II

2:00-4:00 pm

Moderator(s):  Nonnie Polderman, BSc, RD

2:00     Vitamin and Mineral Supplementation for Pediatric Dialysis Patients – Caroline Anderson, PhD, RD
3:00     Carnitine Supplementation – Marisa Juarez-Calderon, RD
4:00     Break